Results 131 to 140 of about 5,242 (246)

IQWiG erkennt Zusatznutzen für Belatacept [PDF]

Uro-News, 2012
openaire   +1 more source

IQWiG-Herbst-Symposium 2009

Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 2009
openaire   +1 more source

IQWIG rät zur Thai-Massage [PDF]

CME, 2010
openaire   +1 more source

Reply to Gringras et al. Comment on "Paditz et al. The Pharmacokinetics, Dosage, Preparation Forms, and Efficacy of Orally Administered Melatonin for Non-Organic Sleep Disorders in Autism Spectrum Disorder During Childhood and Adolescence: A Systematic Review. <i>Children</i> 2025, <i>12</i>, 648". [PDF]

Children (Basel)
Paditz E, Renner B, Koch R, Schneider BM, Schlarb AA.   +4 more
europepmc   +1 more source

Genomic tests to guide management of breast cancer in Europe: regulation, reimbursement, adoption, and challenges. [PDF]

Future Oncol
Verrill M, Lux MP, Gligorov J, Geisler J, Duchnowska R, Elsberger B, Martin M.   +6 more
europepmc   +1 more source

Medizinisch-technischer Fortschritt im Gesund-heitswesen: Zentrale Kosten-Nutzen-Bewertung ohne Alternative? [PDF]

, 2011
Arentz, Christine
core  

Germany's Struggle with Prices for Patent-protected Drugs [PDF]

Mathias Kifmann, Sven Neelsen
core  

Implementation of the EU's Health Technology Assessment regulation: where does existing methods guidance require concretization and what are the relevant methodological options? [PDF]

Int J Technol Assess Health Care
Goetz G, Schandelmaier S, Busse R, Wild C, Panteli D.   +4 more
europepmc   +1 more source

PDG72 KEY CRITERIA FOR ACCEPTANCE OF INDIRECT COMPARISONS IN THE BENEFIT ASSESSMENT BY THE G-BA AND BY THE IQWIG

Value in Health, 2019
D. Bonduelle, T. Fischer, I. Schuh, S. Schwarz   +3 more
semanticscholar   +1 more source

PNS266 DIFFERENT INTERPRETATION OF ADDITIONAL EVIDENCE FOR HTA BY THE COMMISSIONED HTA BODY AND THE COMMISSIONING DECISION MAKER IN GERMANY: WHENEVER IQWIG AND FEDERAL JOINT COMMITTEE DISAGREE

Value in Health, 2019
C. Dintsios, F. Worm, J. Ruof, M. Herpers   +3 more
semanticscholar   +1 more source